<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>戈舍瑞林市场份额 &#8211; 元哲咨询</title>
	<atom:link href="https://www.yuanzhezixun.com/tag/gesheruilinshichangfene/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.yuanzhezixun.com</link>
	<description>行业研究专家</description>
	<lastBuildDate>Wed, 01 Sep 2021 02:33:30 +0000</lastBuildDate>
	<language>zh-Hans</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.yuanzhezixun.com/wp-content/uploads/2021/10/cropped-shcrilogo-c-45x45.jpg</url>
	<title>戈舍瑞林市场份额 &#8211; 元哲咨询</title>
	<link>https://www.yuanzhezixun.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>2021-2025年中国戈舍瑞林市场研究报告：2016-2020年销售额CAGR为15.94%</title>
		<link>https://www.yuanzhezixun.com/2021-2025nianzhongguogesheruilinshichangyanjiubaogao/</link>
		
		<dc:creator><![CDATA[Timlee]]></dc:creator>
		<pubDate>Wed, 16 Jun 2021 03:53:51 +0000</pubDate>
				<category><![CDATA[医/药/保健]]></category>
		<category><![CDATA[报告速递]]></category>
		<category><![CDATA[行业资讯]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[GnRH]]></category>
		<category><![CDATA[gonadotropin-releasing hormone]]></category>
		<category><![CDATA[ZOLADEX]]></category>
		<category><![CDATA[乳腺癌]]></category>
		<category><![CDATA[促性腺激素释放激素激动剂]]></category>
		<category><![CDATA[前列腺癌]]></category>
		<category><![CDATA[戈舍瑞林]]></category>
		<category><![CDATA[戈舍瑞林区域分析]]></category>
		<category><![CDATA[戈舍瑞林市场份额]]></category>
		<category><![CDATA[戈舍瑞林市场竞争]]></category>
		<category><![CDATA[戈舍瑞林市场细分]]></category>
		<category><![CDATA[戈舍瑞林市场规模]]></category>
		<category><![CDATA[抗癌药物]]></category>
		<category><![CDATA[抗肿瘤药物]]></category>
		<category><![CDATA[缓释植入剂]]></category>
		<category><![CDATA[诺雷得]]></category>
		<category><![CDATA[阿斯利康]]></category>
		<guid isPermaLink="false">http://www.yuanzhezixun.com/?p=24311</guid>

					<description><![CDATA[戈舍瑞林是一种促性腺激素释放激素激动剂，主要用于治疗晚期乳腺癌和前列腺癌。CRI元哲的调研数据显示，中国市场戈舍瑞林自2016-2020年销售额逐年增长。2020年中国市场戈舍瑞林销售额达到9.9亿元，2016-2020年销售额CAGR为15.94%。<div class='yarpp yarpp-related yarpp-related-rss yarpp-related-none yarpp-template-list'>

没有相关文章
</div>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
